Imaging mass cytometry technology and its application in tumor research

Huang Yiwei, Xiang Tingxiu, Liu Xinghe, Ran Jing, Zhao Yi

PDF(2399 KB)
PDF(2399 KB)
Journal of Chongqing Medical University ›› 2025, Vol. 50 ›› Issue (01) : 6-13. DOI: 10.13406/j.cnki.cyxb.003639
Review

Imaging mass cytometry technology and its application in tumor research

Author information +
History +

Abstract

Multiplex single-cell proteomics technology has become a hot topic in biomedical research,among which imaging mass cytometry(IMC) completely solves the serious problem of cross-color between fluorophores and makes up for the lack of tissue spatial information in single-cell sequencing technology. This technique can label dozens of targets simultaneously on a single tissue section,obtain their expression levels and cell localization at the single-cell level,perform in-depth cell phenotypic in situ analysis,and visually depict single-cell proteome maps from the temporal and spatial levels,and due to its unique technical advantages,it has become a powerful tool in the field of tumor research. This article elaborates on the technical principle of IMC and summarizes the advances in the application of IMC in cell phenotype identification,biomarker detection,tumor immunomodulatory determination,tumor heterogeneity differentiation,clinical prognosis guidance,and response prediction by analyzing recent cases,so as to promote the further integration of tumor spatial omics with existing technologies.

Key words

imaging mass cytometry / spatial proteome / single-cell analysis / tumor microenvironment / tumor markers

Cite this article

Download Citations
Huang Yiwei , Xiang Tingxiu , Liu Xinghe , et al . Imaging mass cytometry technology and its application in tumor research. Journal of Chongqing Medical University. 2025, 50(01): 6-13 https://doi.org/10.13406/j.cnki.cyxb.003639

References

1
Schreiber RD Old LJ Smyth MJ. Cancer immunoediting:integrating immunity’s roles in cancer suppression and promotion[J]. Science2011331(6024):1565-1570.
2
Topalian SL Hodi FS Brahmer JR,et al. Safety,activity,and immune correlates of anti-PD-1 antibody in cancer[J]. N Engl J Med2012366(26):2443-2454.
3
Chang Q Ornatsky OI Siddiqui I,et al. Imaging mass cytometry[J]. Cytometry A201791(2):160-169.
4
Gohil SH Iorgulescu JB Braun DA,et al. Applying high-dimensional single-cell technologies to the analysis of cancer immunotherapy[J]. Nat Rev Clin Oncol202118(4):244-256.
5
Cotechini T Jones O Hindmarch CCT. Imaging mass cytometry in immuno-oncology[M]// The Tumor Microenvironment. New York:Humana,2023:1-15.
6
Giesen C Wang HA Schapiro D,et al. Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry[J]. Nat Methods201411(4):417-422.
7
Glasson Y Chépeaux LA Dumé AS,et al. Single-cell high-dimensional imaging mass cytometry:one step beyond in oncology[J]. Semin Immunopathol202345(1):17-28.
8
Han GJ Chen SY Gonzalez VD,et al. Atomic mass tag of bismuth-209 for increasing the immunoassay multiplexing capacity of mass cytometry[J]. Cytometry A201791(12):1150-1163.
9
Gerdtsson E Pore M Thiele JA,et al. Multiplex protein detection on circulating tumor cells from liquid biopsies using imaging mass cytometry[J]. Converg Sci Phys Oncol20184(1):015002.
10
Allo B Lou XD Bouzekri A,et al. Clickable and high-sensitivity metal-containing tags for mass cytometry[J]. Bioconjug Chem201829(6):2028-2038.
11
Rovira-Clavé X Jiang SZ Bai YH,et al. Subcellular localization of biomolecules and drug distribution by high-definition ion beam imaging[J]. Nat Commun202112(1):4628.
12
Catena R Montuenga LM Bodenmiller B. Ruthenium counterstaining for imaging mass cytometry[J]. J Pathol2018244(4):479-484.
13
Ijsselsteijn ME van der Breggen R Farina Sarasqueta A,et al. A 40-marker panel for high dimensional characterization of cancer immune microenvironments by imaging mass cytometry[J]. Front Immunol201910:2534.
14
Baars MJD Sinha N Amini M,et al. MATISSE:a method for improved single cell segmentation in imaging mass cytometry[J]. BMC Biol202119(1):99.
15
Hoch T Schulz D Eling N,et al. Multiplexed imaging mass cytometry of the chemokine milieus in melanoma characterizes features of the response to immunotherapy[J]. Sci Immunol20227(70):eabk1692.
16
Baharlou H Canete NP Cunningham AL,et al. Mass cytometry imaging for the study of human diseases-applications and data analysis strategies[J]. Front Immunol201910:2657.
17
Chang Q Ornatsky OI Siddiqui I,et al. Biodistribution of cisplatin revealed by imaging mass cytometry identifies extensive collagen binding in tumor and normal tissues[J]. Sci Rep20166:36641.
18
Carpenter AE Jones TR Lamprecht MR,et al. CellProfiler:image analysis software for identifying and quantifying cell phenotypes[J]. Genome Biol20067(10):R100.
19
Schapiro D Jackson HW Raghuraman S,et al. histoCAT:analysis of cell phenotypes and interactions in multiplex image cytometry data[J]. Nat Methods201714(9):873-876.
20
Fischer JR Jackson HW de Souza N,et al. Multiplex imaging of breast cancer lymph node metastases identifies prognostic single-cell populations independent of clinical classifiers[J]. Cell Rep Med20234(3):100977.
21
Jackson HW Fischer JR Zanotelli VRT,et al. The single-cell pathology landscape of breast cancer[J]. Nature2020578(7796):615-620.
22
Yi QJ Wang J Liu TT,et al. scRNA-Seq and imaging mass cytometry analyses unveil iNKT cells-mediated anti-tumor immunity in pancreatic cancer liver metastasis[J]. Cancer Lett2023561:216149.
23
Mi QS Dimitrion P Hamzavi I,et al. Dysregulated CD38 expression in blood and skin immune cells of patients with hidradenitis suppurativa[J/OL]. Res Sq2023[epub ahead of print].doi: 10.21203/rs.3.rs-2609421/v1 .
24
Ravi VM Will P Kueckelhaus J,et al. Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma[J]. Cancer Cell202240(6):639-655.
25
Funingana IG Bedia JS Huang YW,et al. Multiparameter single-cell proteomic technologies give new insights into the biology of ovarian tumors[J]. Semin Immunopathol202345(1):43-59.
26
Krop J van der Meeren LE van der Hoorn MP,et al. Identification of a unique intervillous cellular signature in chronic histiocytic intervillositis[J]. Placenta2023139:34-42.
27
Le Rochais M Hémon P Ben-Guigui D,et al. Deciphering the maturation of tertiary lymphoid structures in cancer and inflammatory diseases of the digestive tract using imaging mass cytometry[J]. Front Immunol202314:1147480.
28
Roelands J van der Ploeg M Ijsselsteijn ME,et al. Transcriptomic and immunophenotypic profiling reveals molecular and immunological hallmarks of colorectal cancer tumourigenesis[J]. Gut202372(7):1326-1339.
29
Sorin M Karimi E Rezanejad M,et al. Single-cell spatial landscape of immunotherapy response reveals mechanisms of CXCL13 enhanced antitumor immunity[J]. J Immunother Cancer202311(2):e005545.
30
Wang XQ Danenberg E Huang CS,et al. Spatial predictors of immunotherapy response in triple-negative breast cancer[J]. Nature2023621(7980):868-876.
31
Sanmamed MF Nie XX Desai SS,et al. A burned-out CD8+ T-cell subset expands in the tumor microenvironment and curbs cancer immunotherapy[J]. Cancer Discov202111(7):1700-1715.
32
Xiang HD Ramil CP Hai J,et al. Cancer-associated fibroblasts promote immunosuppression by inducing ROS-generating monocytic MDSCs in lung squamous cell carcinoma[J]. Cancer Immunol Res20208(4):436-450.
33
van Dam S Baars MJD Vercoulen Y. Multiplex tissue imaging:spatial Revelations in the tumor microenvironment[J]. Cancers202214(13):3170.
34
Karimi E Yu MW Maritan SM,et al. Single-cell spatial immune landscapes of primary and metastatic brain tumours[J]. Nature2023614(7948):555-563.
35
Rahim MK Okholm TLH Jones KB,et al. Dynamic CD8+ Tcell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes[J]. Cell2023186(6):1127-1143.
36
Apollonio B Spada F Petrov N,et al. Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma[J]. J Clin Invest2023133(13):e166070.
37
Mancino C Pasto A de Rosa E,et al. Immunomodulatory biomimetic nanoparticles target articular cartilage trauma after systemic administration[J]. Heliyon20239(6):e16640.
38
Heiland DH Ravi VM Will P,et al. Spatiotemporal heterogeneity of glioblastoma is dictated by microenvironmental interference[J]. Brain Spine20211:100550.
39
Lin QY Zhou YQ Ma J,et al. Single-cell analysis reveals the multiple patterns of immune escape in the nasopharyngeal carcinoma microenvironment[J]. Clin Transl Med202313(6):e1315.
40
Danielli SG Porpiglia E De Micheli AJ,et al. Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance[J]. Sci Adv20239(6):eade9238.
41
Yao LY He FN Zhao QY,et al. Spatial multiplexed protein profiling of cardiac ischemia-reperfusion injury[J]. Circ Res2023133(1):86-103.
42
He JZ Chen Y Zeng FM,et al. Spatial analysis of stromal signatures identifies invasive front carcinoma-associated fibroblasts as suppressors of anti-tumor immune response in esophageal cancer[J]. J Exp Clin Cancer Res202342(1):136.
43
Robert M Chépeaux LA Glasson Y,et al. Comprehensive analysis of cell lineages involved in giant cell arteritis pathogenesis using highly multiplexed imaging mass cytometry[J]. Autoimmun Rev202322(1):103216.
44
Zabransky DJ Danilova L Leatherman JM,et al. Profiling of syngeneic mouse HCC tumor models as a framework to understand anti-PD-1 sensitive tumor microenvironments[J]. Hepatology202377(5):1566-1579.
45
Eng J Bucher E Hu Z,et al. Robust biomarker discovery through multiplatform multiplex image analysis of breast cancer clinical cohorts[J/OL]. bioRxiv2023[epub ahead of print]. doi: 10.1101/2023.01.31.525753 .
46
Chen J Amoozgar Z Liu X,et al. Reprogramming intrahepatic cholangiocarcinoma immune microenvironment by chemotherapy and CTLA-4 blockade enhances anti-PD1 therapy[J/OL]. bioRxiv2023[epub ahead of print].doi: 10.1101/2023.01.26.525680 .
47
Sorin M Rezanejad M Karimi E,et al. Single-cell spatial landscapes of the lung tumour immune microenvironment[J]. Nature2023614(7948):548-554.
48
Wang V Liu ZC Martinek J,et al. Computational immune synapse analysis reveals T-cell interactions in distinct tumor microenvironments[J/OL]. Res Sq2023[epub ahead of print].doi: 10.21203/rs.3.rs-2968528/v1 .
49
Cao YS Chang Q Cabanero M,et al. Tumor platinum concentrations and pathological responses following cisplatin-containing chemotherapy in gastric cancer patients[J]. J Gastrointest Cancer201950(4):801-807.
50
Cao YS Chang Q Zhang WJ,et al. Skin platinum deposition in colorectal cancer patients following oxaliplatin-based therapy[J]. Cancer Chemother Pharmacol201984(6):1195-1200.
51
Sayin K Üngördü A. Investigation of anticancer properties of caffeinated complexes via computational chemistry methods[J]. Spectrochim Acta A Mol Biomol Spectrosc2018193:147-155.
52
Lau JKC Deubel DV. Hydrolysis of the anticancer drug cisplatin:pitfalls in the interpretation of quantum chemical calculations[J]. J Chem Theory Comput20062(1):103-106.
53
Alvarado-Soto L Ramirez-Tagle R. A theoretical study of the binding of[Re₆Se₈(OH)₂(H₂O)₄]rhenium clusters to DNA purine base guanine[J]. Materials20158(7):3938-3944.
54
Deo C Abdelfattah AS Bhargava HK,et al. The HaloTag as a general scaffold for far-red tunable chemigenetic indicators[J]. Nat Chem Biol202117(6):718-723.
55
Duncan RR Bergmann A Cousin MA,et al. Multi-dimensional time-correlated single photon counting(TCSPC) fluorescence lifetime imaging microscopy(FLIM) to detect FRET in cells[J]. J Microsc2004215(Pt 1):1-12.
56
Dang JQ Li HX Zhang LL,et al. New Structure Mass Tag based on Zr-NMOF for Multiparameter and Sensitive Single-Cell Interrogating in Mass Cytometry[J]. Adv Mater202133(35):e2008297.
57
Ptacek J Locke D Finck R,et al. Multiplexed ion beam imaging(MIBI) for characterization of the tumor microenvironment across tumor types[J]. Lab Invest2020100(8):1111-1123.
58
Keren L Bosse M Thompson S,et al. MIBI-TOF:a multiplexed imaging platform relates cellular phenotypes and tissue structure[J]. Sci Adv20195(10):eaax5851.
59
Parrot D Papazian S Foil D,et al. Imaging the unimaginable:desorption electrospray ionization-imaging mass spectrometry(DESI-IMS) in natural product research[J]. Planta Med201884(9/10):584-593.

Comments

PDF(2399 KB)

Accesses

Citation

Detail

Sections
Recommended

/